On the Precipice of Change: Paradigm Shifts in Psychedelic Assisted Therapy (PAT) and the Future of Mental Health

Speakers:

Rick Doblin, President, Multidisciplinary Association for Psychedelic Studies (MAPS)
Isaac Gilmore, Deputy Veteran Affairs Officer, TREAT California; Advisor, Concordia
Loree Sutton, Former New York City Commissioner of Veterans Affairs
Brett Waters, Co-Founder & Executive Director, Reason for Hope

 

With lead Programming partner

“Psychedelics can help people move beyond their understanding of who they are and broaden it.”     

– Rick Doblin

“The FDA views these as shown as safe through clinical trials and potentially much more effective than current treatments we have.”

– Brett Waters

“Something our country desperately needs is more connective tissue between our veteran community and our community at large.”

– Isaac Gilmore

“You haven’t seen complex PTSD until you’ve seen it in a veteran […] Treatment as usual is not the answer.”

– Loree Sutton

Key takeaways & next steps:

  • There is growing attention to psychedelics and their role in transforming mental health. Much progress has been made in researching and advocating for the therapeutic use of psychedelics, particularly MDMA.
  • Psychedelic therapy involves a deep dive into the causes of trauma, emphasizing that patients become their own healers. The therapy focuses on integration and the brain’s plasticity to facilitate long-lasting healing. It’s important to train the next generation to continue the movement for psychedelic therapy and mental health transformation.
  • Access to psychedelic-assisted therapy, not limited to MDMA but also including substances like ketamine, psilocybin, ibogaine, and ayahuasca, should be globalized.
  • TREAT California is a state agency initiative aiming to raise $5 billion for large-scale clinical trials, research, and access to psychedelic therapy. The initiative seeks to collaborate with the NIH, FDA, and DEA and potentially serve as a model for other states.
  • There is a need for bipartisan support in advancing policies that enable access to psychedelic therapies and the implementation of pragmatic measures to reduce research barriers.
  • Veterans lead the charge in advocating for psychedelic therapies, driven by their personal experiences and the proven efficacy of these treatments in addressing complex PTSD and military-related trauma.

Important Notice Regarding Fraudulent Website

We have identified a website operating under www.theconcordiasummit.org that is impersonating Concordia and copying our brand, language, and images. This site is not affiliated with Concordia. Our only official website is www.concordia.net.

If you have shared personal or payment information with the fraudulent site, please contact us immediately at enquiries@concordia.net. 

We are actively working to have the site removed.